United Kingdom · Series B startup

Who invested in NeRRe Therapeutics

3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$74Mraised across 3 rounds since 2012, from 3 sources

$18MSeries A$28MSeries B$28MSeries B
Latest round
Series B, $28MJul 2021
Biggest round
$28MSeries B · Jan 2016
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2014201620182020
$18MSeries A$28MSeries B$28MSeries B
First round
Series A, $18M
Dec 2012
Biggest round
$28M
Series B · Jan 2016
Usual gap between rounds
5.5 years
the median of 2

The rounds

  1. Jul 2021
  2. Jan 2016
    Series B$28M1 new

    Reported by FinSMEs

  3. Dec 2012
    Series A$18M

    No investor was named in the report.

    Reported by biospace.com

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

OrbiMedPrivate equity1round
Novo HoldingsVC firm1round
Forbion Capital PartnersPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about NeRRe Therapeutics

Who invested in NeRRe Therapeutics?

NeRRe Therapeutics's investors include U.S. Venture Partners, OrbiMed, Novo Holdings, Forbion Capital Partners and Fountain Healthcare Partners.

How much has NeRRe Therapeutics raised?

NeRRe Therapeutics has raised $74M across 3 rounds since 2012.

When did NeRRe Therapeutics last raise?

NeRRe Therapeutics's most recent round was a Series B of $28M in Jul 2021.

What was NeRRe Therapeutics's biggest round?

NeRRe Therapeutics's largest round on record is $28M (Series B), in Jan 2016.

Who backed NeRRe Therapeutics first?

NeRRe Therapeutics's first round on record, in Jan 2016, was backed by Fountain Healthcare Partners.

What stage is NeRRe Therapeutics at?

NeRRe Therapeutics's latest named round is a Series B, in Jul 2021.

Where is NeRRe Therapeutics based?

NeRRe Therapeutics is based in the United Kingdom.

Companies like NeRRe Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.